Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of non-HLA genetic polymorphisms in graft-versus-host disease after haematopoietic stem cell transplantation.

International journal of immunogenetics - 1 Oct 2006

Bertinetto F E, Dall'Omo A M, Mazzola G A, Rendine S, Berrino M, Bertola L, Magistroni P, Caropreso P, Falda M, Locatelli F, Busca A, Amoroso A

Abstract excerpt

Graft-versus-host disease (GvHD) is the main complication after haematopoietic stem cells transplantation (HSCT) and acute forms (aGvHD) occur in 20-40% of cases even after donor (D) and recipient (R) HLA matching, apparently because of D/R minor histocompatibility antigen (mHA) mismatches and cytokine polymorphisms. The genotype of cytokines and mHA of 77 haematological R following HSCT from HLA identical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytokines
Share to Graft vs Host Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hematologic Diseases

Share to Hematopoietic Stem Cell Transplantation

Share to HLA Antigens

Share to Interleukin-1

Share to Interleukin-10

Share to Living Donors

Source

Identifiers

PMID: 16984283
DOI: 10.1111/j.1744-313X.2006.00630.x

Genes

TNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of non-HLA genetic polymorphisms in graft-versus-host disease after haematopoietic stem cell transplantation.PMID 16984283Read ↗

The impact of cytokine gene polymorphisms on the outcome of HLA matched sibling hematopoietic stem cell transplantation.Semantic proximity Read ↗

Association of cytokine gene polymorphisms with the complications of allogeneic haematopoietic stem cell transplantation.Semantic proximity Read ↗

Non-HLA immunogenetic polymorphisms and the risk of complications after allogeneic hemopoietic stem-cell transplantation.Semantic proximity Read ↗

BOTH GENETIC AND CLINICAL FACTORS PREDICT THE DEVELOPMENT OF GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONSemantic proximity Read ↗

Polymorphisms of cytokine and innate immunity genes and GVHD.Semantic proximity Read ↗

Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants.Semantic proximity Read ↗

Non-HLA genetics and predicting outcome in HSCT.Semantic proximity Read ↗

Cytokine gene polymorphisms and graft-versus-host disease in children after matched sibling hematopoietic stem cell transplantation: a single-center experience.Semantic proximity Read ↗

IL2 and TNFA gene polymorphisms and the risk of graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.Semantic proximity Read ↗

Genetic polymorphisms predicting the outcome of bone marrow transplantsSemantic proximity Read ↗

The effects of gene polymorphisms on susceptibility to acute GVHD and survival of allogeneic HSCT recipients: IL-10 gene polymorphisms as a more accessible target to predict prognosis.Semantic proximity Read ↗

Polymorphisms of interleukin‐1α constitute independent risk factors for chronic graft‐versus‐host disease after allogeneic bone marrow transplantationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.